GLI Pathogenesis-Related 1 (GLIPR1) Peptide
GLIPR1
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits GLIPR1
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- RTVP-1 peptide corresponds to 12 amino acids of RTVP-1.
-
-
- Indications d'application
- RTVP-1 Peptide is used for blocking the activity of RTVP-1 antibody . The RTVP-1 antibody ships at 0.5 mg/mL and the RTVP-1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- RTVP-1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Synonymes
- CRISP7 Peptide, GLIPR Peptide, RTVP1 Peptide, 2410114O14Rik Peptide, RTVP-1 Peptide, mRTVP-1 Peptide, GLIPR1 Peptide, zgc:65887 Peptide, GLI pathogenesis related 1 Peptide, GLI pathogenesis-related 1 Peptide, GLI pathogenesis-related 1 (glioma) Peptide, GLI pathogenesis-related 1b Peptide, GLIPR1 Peptide, Glipr1 Peptide, glipr1b Peptide
- ID gène
- 11010
- NCBI Accession
- NP_006842
- OMIM
- 110825980
- UniProt
- P48060
-
Vous êtes ici:
